3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Prostatic Neoplasms
16
Sarcoma
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
5
Uterine Cervical Neoplasms
4
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Pancreatic Neoplasms
2
Neurofibrosarcoma
2
Neoplasms
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Advanced Refractory Solid Tumors
2
Uterine Neoplasms
1
Urothelial Cancer
1
Urogenital Neoplasms
1
Interventions
Tamoxifen
3
pyrotinib
2
abemaciclib
2
Metformin
2
Letrozole
2
Exercise
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
palbociclib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tumor Burden
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Sodium Chloride
1
Self-Help Groups
1
Saline Solution
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Breast Cancer Female
×
Radiation Dose Hypofractionation
×
Clear all
NCT03127995
2024-04-09
HYPOG-01
UNICANCER
Phase NA
Active not recruiting
1,265 enrolled